Search Results

Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey.

• Authors : Brister D; Department of Medicine, McMaster University Medical Centre, 3U9, 1280 Main St. West, Hamilton, ON, L8S 4L8, Canada.; Khan S

Subjects: Cough*/Cough*/Cough*/epidemiology ; Quality of Life* ; Cost of Illness*

• Source: Lung [Lung] 2024 Aug; Vol. 202 (4), pp. 415-424. Date of Electronic Publication: 2024 Jun 12.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7701875 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey

• Authors : Khan, Sana; Brister, Danica; Abraham, Ted

• Source: PLoS ONE. August 1, 2024, Vol. 19 Issue 8, e0308275

Record details

Canadian Health Care Professionals' Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional Survey.

• Authors : Kum, Elena; Brister, Danica; Diab, Nermin

Subjects: COUGH; MEDICAL personnel; GENERAL practitionersCANADA

• Source: Lung; Feb2023, Vol. 201 Issue 1, p47-55, 9p

Record details

Burden of chronic cough on social participation, healthcare resource utilisation and activities of daily living in the Canadian Longitudinal Study on Aging (CLSA).

• Authors : Satia I; McMaster University, Department of Medicine, Hamilton, Canada; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Canada

Subjects: Activities of Daily Living* ; Social Participation*; Male

• Source: Respiratory medicine [Respir Med] 2023 Nov-Dec; Vol. 219, pp. 107431. Date of Electronic Publication: 2023 Oct 24.Publisher: Elsevier Country of Publication: England NLM ID: 8908438 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3064

Record details

CT airway remodelling and chronic cough.

• Authors : Abozid H; CanCOLD Collaborative research Group and the Canadian Respiratory Research Network

Subjects: Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/complications ; Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/Pulmonary Disease, Chronic Obstructive*/diagnostic imaging ; Pulmonary Emphysema*

• Source: BMJ open respiratory research [BMJ Open Respir Res] 2023 May; Vol. 10 (1).Publisher: BMJ Publishing Group Ltd & British Thoracic Society Country of Publication: England NLM ID: 101638061 Publication Model: Print Cited Medium:

Record details

Algernon Pharmaceuticals Announces Completion of Enrollment in its Phase 2 Study of Ifenprodil for IPF and Chronic Cough.

• Source: Marketwired. 2022.

Record details

Algernon Pharmaceuticals Announces Completion of Enrollment in its Phase 2 Study of Ifenprodil for IPF and Chronic Cough.

• Source: GlobeNewswire. 2022.

Record details

Algernon Pharmaceuticals Announces Positive Feedback from U.S. FDA for Phase 2b Ifenprodil Chronic Cough Study.

• Source: GlobeNewswire. 2022.

Record details

Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial.

• Source: Marketwired. 2021.

Record details

Algernon Pharmaceuticals Projects Full Enrollment for Phase 2 IPF and Chronic Cough Trial.

• Source: GlobeNewswire. 2021.

Record details